UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046887
Receipt number R000053372
Scientific Title The efficacy study of the e-sports supplement
Date of disclosure of the study information 2022/02/11
Last modified on 2024/01/06 15:05:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy study of the e-sports supplement

Acronym

The efficacy study of the e-sports supplement

Scientific Title

The efficacy study of the e-sports supplement

Scientific Title:Acronym

The efficacy study of the e-sports supplement

Region

Japan


Condition

Condition

Healthy Japanese subjects

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To study the efficacy of the e-sports supplement

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Autonomic nerve measurement

Key secondary outcomes

Emotional evaluation
Brain working memory
Stress marker
Subjective fatigue


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Duration:14 days
Intake of test food 1

Interventions/Control_2

Duration:14 days
Intake of test food 2

Interventions/Control_3

Duration:14 days
Intake of placebo

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Male students playing e-sports

Key exclusion criteria

Persons who have food allergy to soybeen, cannot stop drinking alcohol from the experimental days and caffeine and energy drink on the experimental days

Target sample size

21


Research contact person

Name of lead principal investigator

1st name Hirohisa
Middle name
Last name Isogai

Organization

Kyushu Sangyo University

Division name

Human Science

Zip code

813-0004

Address

2-3-1 Matsukadai, Higashi-ku, Fukuoka City, Fukuoka Prefecture

TEL

090-9495-5291

Email

isogai@ip.kyusan-u.ac.jp


Public contact

Name of contact person

1st name Yoshiko
Middle name
Last name Saito

Organization

Behavior Assessment System Laboratory

Division name

Director Researcher

Zip code

815-0032

Address

1-28-23 Shiobaru, Minami-ku, Fukuoka City, Fukuoka Prefecture

TEL

090-4353-9416

Homepage URL


Email

saitou@baslab.or.jp


Sponsor or person

Institute

Behavior Assessment System Laboratory

Institute

Department

Personal name



Funding Source

Organization

NOF CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Graduate School of Life Science and Systems Engineering, Kyushu Institute of Technology

Address

2-4 Hibikino, Wakamatsu-ku, Kitakyushu City, Fukuoka Prefecture

Tel

093-695-6000

Email

sei-soumu@jimu.kyutech.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 01 Month 26 Day

Date of IRB

2022 Year 02 Month 14 Day

Anticipated trial start date

2022 Year 02 Month 14 Day

Last follow-up date

2022 Year 03 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 02 Month 11 Day

Last modified on

2024 Year 01 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053372